RecruitingNot ApplicableNCT06370780

Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically


Sponsor

University of California, Los Angeles

Enrollment

1,000 participants

Start Date

Feb 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Have access to a personal smartphone device;
  • Over 18 years of age;
  • Speak English or Spanish;
  • Living with HIV
  • Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression;
  • Active substance use or mental health disorder;
  • Willing and able to provide written informed consent to take part in the study.

Exclusion Criteria3

  • Unwilling or unable to provide reliable contact information;
  • Unwilling to provide blood sample for HIV virology testing;
  • Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.

Interventions

OTHEREPI LOVE

Observational cohort only


Locations(1)

University of California, Los Angeles

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06370780


Related Trials